- Home
- QD vs CMRX Comparison
QD vs CMRX Comparison
Compare QD & CMRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- QD
- CMRX
- Stock Information
- Founded
- QD 2014
- CMRX 2000
- Country
- QD China
- CMRX United States
- Employees
- QD N/A
- CMRX N/A
- Industry
- QD Finance: Consumer Services
- CMRX Biotechnology: Pharmaceutical Preparations
- Sector
- QD Finance
- CMRX Health Care
- Exchange
- QD Nasdaq
- CMRX Nasdaq
- Market Cap
- QD 433.7M
- CMRX 394.1M
- IPO Year
- QD 2017
- CMRX 2013
- Fundamental
- Price
- QD $2.63
- CMRX $8.50
- Analyst Decision
- QD
- CMRX Hold
- Analyst Count
- QD 0
- CMRX 4
- Target Price
- QD N/A
- CMRX $8.51
- AVG Volume (30 Days)
- QD 464.7K
- CMRX 8.6M
- Earning Date
- QD 03-20-2025
- CMRX 03-21-2025
- Dividend Yield
- QD N/A
- CMRX N/A
- EPS Growth
- QD N/A
- CMRX N/A
- EPS
- QD 0.03
- CMRX N/A
- Revenue
- QD $32,502,011.00
- CMRX $212,000.00
- Revenue This Year
- QD N/A
- CMRX $2,685.38
- Revenue Next Year
- QD N/A
- CMRX $1,050.23
- P/E Ratio
- QD $99.94
- CMRX N/A
- Revenue Growth
- QD 4.27
- CMRX N/A
- 52 Week Low
- QD $1.52
- CMRX $0.75
- 52 Week High
- QD $3.34
- CMRX $8.53
- Technical
- Relative Strength Index (RSI)
- QD 41.24
- CMRX 83.50
- Support Level
- QD $2.59
- CMRX $8.41
- Resistance Level
- QD $2.74
- CMRX $8.52
- Average True Range (ATR)
- QD 0.13
- CMRX 0.02
- MACD
- QD -0.01
- CMRX -0.13
- Stochastic Oscillator
- QD 4.17
- CMRX 70.00
About QD Qudian Inc. each representing one
Qudian Inc is a consumer-oriented technology company engaged in the operation of online platforms to provide small consumer credit products in the People's Republic of China. It aims to empower financial institutions with its technological capabilities, help them improve marketing and operating efficiency, and enable financial institutions to efficiently connect their diversified financial products with scene traffic across the entire network It derives a majority of its revenue from the People's Republic of China.
About CMRX Chimerix Inc.
Chimerix Inc. is a biopharmaceutical company based in the United States that engages in the research, development, and commercialization of medicines. Its portfolio includes treatment for acute myeloid leukemia (or AML) and antiviral treatment for smallpox. The company generates revenue through revenue related to non-refundable upfront fees, royalties and milestone payments earned under license agreements, also by royalty revenue related to sales of TEMBEXA made by Emergent after the Asset Sale. The company operates only in one business segment namely pharmaceuticals.